Skip to main content

Published locations for Ibrutinib sustained responses in refractory CLL in long-term follow-up

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ibrutinib sustained responses in refractory CLL in long-term follow-up

User login

  • Reset your password
  • /content/ibrutinib-sustained-responses-refractory-cll-long-term-follow
  • /fedprac/article/197653/cll/ibrutinib-sustained-responses-refractory-cll-long-term-follow
  • /hematologynews/article/197653/cll/ibrutinib-sustained-responses-refractory-cll-long-term-follow
  • /oncologypractice/article/197653/cll/ibrutinib-sustained-responses-refractory-cll-long-term-follow
  • /fedprac/avaho/article/197653/cll/ibrutinib-sustained-responses-refractory-cll-long-term-follow
  • /hematology-oncology/article/197653/cll/ibrutinib-sustained-responses-refractory-cll-long-term-follow
  • /hematologytimes/article/197653/cll/ibrutinib-sustained-responses-refractory-cll-long-term-follow
  • /b-cell-lymphoma-icymi/article/197653/cll/ibrutinib-sustained-responses-refractory-cll-long-term